Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Improving the Quality of Life of Patients with Parkinson's Disease using Deep Brain Stimulation and Magnetoencephalography
FY 2017-18
Summary
Parkinson's disease is the second most common degenerative brain disorder and affects over 100,000 Canadians. Patients suffer from tremor, rigid muscles and slowed movement and when medications are no longer effective in treating these symptoms patients receive a treatment called Deep Brain Stimulation (DBS). DBS is a surgical procedure which involves the insertion of a 'brain pacemaker' through the skull. This device is programmed to send electrical signals to certain areas of the brain to relieve symptoms. Despite the widespread use of DBS, the mechanism by which it works is unknown; as a result, conventional DBS programming is subjective and requires multiple patient visits.
My project involves the integration of computers and brain activity to optimize DBS settings in patients with Parkinson's disease. Since every patient has a unique set of symptoms and response to DBS, I will examine how individual brain activity responds to different DBS settings. Brain activity will be measured in the form of magnetic fields and compared to tremor activity and motor function. We expect that the optimization of DBS settings based on patients' brain activity will improve symptom relief and reduce side effects, thereby improving patient quality of life through increased mobility and independence. Fewer clinical visits to adjust DBS settings will also benefit patients and their caregivers and result in lower healthcare costs.
There is a growing need to improve the efficiency of DBS programming using technology since DBS is becoming more popular in Parkinson's disease. Our group is also the first to use DBS to treat depression, anorexia and Alzheimer's disease for which programming guidelines do not exist. This innovative project will improve the efficacy of DBS to provide a better quality of life to Canadians suffering from Parkinson's disease and other neurological and psychiatric disorders.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
376550
Name
Harmsen Irene
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Improving the Quality of Life of Patients with Parkinson's Disease using Deep Brain Stimulation and Magnetoencephalography
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Brain Circuits; Clinical Outcomes; Deep Brain Stimulation; Functional Neurosurgery; Magnetoencephalography; Neuroimaging; Neurophysiology; Parkinson'S Disease
Abstract
Parkinson's disease is the second most common degenerative brain disorder and affects over 100,000 Canadians. Patients suffer from tremor, rigid muscles and slowed movement and when medications are no longer effective in treating these symptoms patients receive a treatment called Deep Brain Stimulation (DBS). DBS is a surgical procedure which involves the insertion of a 'brain pacemaker' through the skull. This device is programmed to send electrical signals to certain areas of the brain to relieve symptoms. Despite the widespread use of DBS, the mechanism by which it works is unknown; as a result, conventional DBS programming is subjective and requires multiple patient visits.
My project involves the integration of computers and brain activity to optimize DBS settings in patients with Parkinson's disease. Since every patient has a unique set of symptoms and response to DBS, I will examine how individual brain activity responds to different DBS settings. Brain activity will be measured in the form of magnetic fields and compared to tremor activity and motor function. We expect that the optimization of DBS settings based on patients' brain activity will improve symptom relief and reduce side effects, thereby improving patient quality of life through increased mobility and independence. Fewer clinical visits to adjust DBS settings will also benefit patients and their caregivers and result in lower healthcare costs.
There is a growing need to improve the efficiency of DBS programming using technology since DBS is becoming more popular in Parkinson's disease. Our group is also the first to use DBS to treat depression, anorexia and Alzheimer's disease for which programming guidelines do not exist. This innovative project will improve the efficacy of DBS to provide a better quality of life to Canadians suffering from Parkinson's disease and other neurological and psychiatric disorders.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Harmsen, Irene
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~